MNG
Manning & Napier Group’s Takeda Pharmaceutical TAK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $3.78M | Sell |
271,786
-26,100
| -9% | -$363K | 0.04% | 196 |
|
2023
Q4 | $4.25M | Sell |
297,886
-4,381
| -1% | -$62.5K | 0.05% | 190 |
|
2023
Q3 | $4.68M | Sell |
302,267
-3,189
| -1% | -$49.3K | 0.06% | 188 |
|
2023
Q2 | $4.8M | Buy |
305,456
+22,939
| +8% | +$360K | 0.05% | 196 |
|
2023
Q1 | $4.66M | Sell |
282,517
-7,646
| -3% | -$126K | 0.05% | 218 |
|
2022
Q4 | $4.53M | Sell |
290,163
-5,543
| -2% | -$86.5K | 0.06% | 218 |
|
2022
Q3 | $3.84M | Buy |
295,706
+907
| +0.3% | +$11.8K | 0.05% | 232 |
|
2022
Q2 | $4.14M | Buy |
294,799
+3,397
| +1% | +$47.7K | 0.05% | 232 |
|
2022
Q1 | $4.17M | Sell |
291,402
-27,903
| -9% | -$399K | 0.04% | 237 |
|
2021
Q4 | $4.35M | Sell |
319,305
-2,717
| -0.8% | -$37K | 0.04% | 243 |
|
2021
Q3 | $5.27M | Sell |
322,022
-2,207
| -0.7% | -$36.1K | 0.05% | 226 |
|
2021
Q2 | $5.46M | Buy |
+324,229
| New | +$5.46M | 0.04% | 235 |
|